MITERA Children’s Hospital: Monitoring Program for Cancer Survivors
15 February 2016
The young cancer survivors will have the opportunity to visit physicians of various medical specialties who are affiliated with the program, as well as undergo the necessary clinical, blood and imaging tests, after having been referred by the NiKa Clinic. A personalized monitoring program will then be drawn up, once the screening has been concluded.
The annual program will cater for individuals over 18 years of age and will be offered at the special rate of 50 euros. For further information, survivors may contact the NiKa Clinic on +30 210 6869431.
As Dr Helen Vasilatou-Kosmidis, Pediatric Hematologist-Oncologist and Director of the MITERA Pediatric & Adolescent Oncology Clinic, stated, “The NiKa Clinic was created by the MITERA Pediatric & Adolescent Oncology Clinic with the aim of monitoring young adults who have been cured of cancer. As a matter of fact, to mark the two-year anniversary of the Clinic, we recently organized the 2nd scientific meeting, which also focused on issues concerning young cancer survivors. This program has received the support of Kyttaro, the Greek Cancer Survivors Association, and commenced out of the pressing need to monitor young cancer survivors, given that we now are well aware of the fact that these individuals face an increased risk of developing certain medical conditions due to their prior disease and the administration of cancer-specific therapy.”
Commenting on the initiative, MITERA Hospital’s CEO, Mr Andreas Kartapanis, noted, “The establishment of the Pediatric & Adolescent Oncology Clinic as well as the first NiKa Clinic in Greece, coupled with the experience gained by MITERA Children’s Hospitals in the over 10 years it has been operating, have made it possible for us to make young patients and their suffering parents smile again. In the context of its Corporate Social Responsibilities initiatives, and aided by the associated physicians who volunteer their knowledge and time, MITERA may offer quality and essential care to young individuals who have been cured of cancer.”
